TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies.

Mark A Dawson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.